What is Micro-Distributing?
Micro-Distributing operates as a comprehensive provider of drug and alcohol testing, alongside sophisticated employee screening solutions. Since its inception in 1999, the firm has evolved into a one-source provider, leveraging FDA-approved devices and SAMHSA-certified laboratory services to serve a diverse clientele ranging from small local enterprises to Fortune 500 corporations and government entities. The company distinguishes itself through a commitment to accuracy, regulatory compliance, and a robust logistics network that supports high-volume testing requirements. By integrating background investigative services with diagnostic testing, Micro-Distributing addresses the critical need for risk mitigation in employment, judicial, and educational environments, effectively positioning itself as an essential partner for organizations prioritizing workforce integrity and safety.
How much funding has Micro-Distributing raised?
Micro-Distributing has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Micro-Distributing
PPP
Public-Private Partnership
What's next for Micro-Distributing?
With the successful closure of this late-stage financing, Micro-Distributing is poised to accelerate its strategic growth initiatives. The capital will likely be deployed to further refine its proprietary product suite and deepen its penetration into international markets where demand for standardized screening services is rising. Furthermore, the company is expected to leverage its enhanced financial standing to pursue strategic partnerships that bolster its technological capabilities in information management and health diagnostics. As the regulatory landscape for workplace screening continues to evolve, Micro-Distributing's focus on maintaining high-quality, scalable solutions will be paramount in sustaining its competitive advantage and driving long-term value for its stakeholders.
See full Micro-Distributing company page
